| Schedule of Segment Reporting Information, by Segment |
The information by segment is as follows (in thousands): | | | | | | | | | | | | | | 2016 | | 2015 | | 2014 | Revenues from external customers | | | | | | North America/HME | $ | 397,702 |
| | $ | 474,196 |
| | $ | 507,867 |
| Institutional Products Group | 64,413 |
| | 87,137 |
| | 102,796 |
| Europe | 540,013 |
| | 536,463 |
| | 610,555 |
| Asia/Pacific | 45,346 |
| | 44,542 |
| | 48,945 |
| Consolidated | $ | 1,047,474 |
| | $ | 1,142,338 |
| | $ | 1,270,163 |
| Intersegment revenues | | | | | | North America/HME | $ | 100,793 |
| | $ | 111,321 |
| | $ | 84,247 |
| Institutional Products Group | 2,885 |
| | 997 |
| | 6,711 |
| Europe | 10,139 |
| | 9,958 |
| | 8,938 |
| Asia/Pacific | 19,366 |
| | 20,661 |
| | 26,173 |
| Consolidated | $ | 133,183 |
| | $ | 142,937 |
| | $ | 126,069 |
| Depreciation and amortization | | | | | | North America/HME (1) | $ | 5,932 |
| | $ | 7,549 |
| | $ | 9,077 |
| Institutional Products Group | 254 |
| | 1,980 |
| | 7,656 |
| Europe | 7,062 |
| | 7,183 |
| | 11,111 |
| Asia/Pacific | 1,349 |
| | 1,463 |
| | 2,406 |
| All Other (2) | 38 |
| | 29 |
| | 173 |
| Discontinued Operations | — |
| | — |
| | 518 |
| Consolidated (1) | $ | 14,635 |
| | $ | 18,204 |
| | $ | 30,941 |
| | | | | | |
| | | | | | | | | | | | | | 2016 | | 2015 | | 2014 | Net interest expense (income) | | | | | | North America/HME (1) | $ | 15,119 |
| | $ | 3,305 |
| | $ | 2,196 |
| Institutional Products Group | 191 |
| | 1,028 |
| | 2,244 |
| Europe | 197 |
| | (444 | ) | | (209 | ) | Asia/Pacific | 103 |
| | 82 |
| | 149 |
| Consolidated (1) | $ | 15,610 |
| | $ | 3,971 |
| | $ | 4,380 |
| Operating income (loss) | | | | | | North America/HME | $ | (37,748 | ) | | $ | (29,245 | ) | | $ | (59,124 | ) | Institutional Products Group | 5,693 |
| | 7,834 |
| | 6,248 |
| Europe | 33,994 |
| | 39,794 |
| | 50,169 |
| Asia/Pacific | (1,436 | ) | | (3,493 | ) | | (7,463 | ) | All Other (2) | (20,657 | ) | | (20,712 | ) | | (24,507 | ) | Charge related to restructuring activities | (2,447 | ) | | (1,971 | ) | | (11,112 | ) | Gains on sales of businesses | 7,386 |
| | 24 |
| | — |
| Asset write-off (3) | — |
| | — |
| | (13,041 | ) | Consolidated operating loss | (15,215 | ) | | (7,769 | ) | | (58,830 | ) | Net gain on convertible derivatives | 1,268 |
| | — |
| | — |
| Net Interest expense | (15,610 | ) | | (3,971 | ) | | (4,380 | ) | Loss from continuing operations before income taxes | $ | (29,557 | ) | | $ | (11,740 | ) | | $ | (63,210 | ) | Assets | | | | | | North America/HME (4) | $ | 261,538 |
| | $ | 203,851 |
| | $ | 209,122 |
| Institutional Products Group (5) | 38,657 |
| | 38,730 |
| | 42,692 |
| Europe | 575,981 |
| | 557,740 |
| | 638,896 |
| Asia/Pacific | 25,703 |
| | 24,421 |
| | 30,231 |
| All Other (2) | 1,864 |
| | 1,752 |
| | 15,647 |
| Assets Held for Sale (4) (5) | — |
| | 11,649 |
| | 27,143 |
| Consolidated | $ | 903,743 |
| | $ | 838,143 |
| | $ | 963,731 |
| Long-lived assets | | | | | | North America/HME (4) | $ | 70,553 |
| | $ | 49,141 |
| | $ | 44,727 |
| Institutional Products Group (3) | 30,603 |
| | 30,278 |
| | 33,487 |
| Europe | 388,724 |
| | 391,533 |
| | 459,957 |
| Asia/Pacific | 2,927 |
| | 3,140 |
| | 4,046 |
| All Other (2) | 1,864 |
| | 1,752 |
| | 15,527 |
| Consolidated | $ | 494,671 |
| | $ | 475,844 |
| | $ | 557,744 |
| Expenditures for assets | | | | | | North America/HME | $ | 3,398 |
| | $ | 1,232 |
| | $ | 2,960 |
| Institutional Products Group | 58 |
| | 212 |
| | 1,232 |
| Europe | 5,580 |
| | 5,058 |
| | 6,708 |
| Asia/Pacific | 1,115 |
| | 969 |
| | 1,417 |
| All Other (2) | — |
| | 51 |
| | — |
| Discontinued Operations | — |
| | — |
| | 10 |
| Consolidated | $ | 10,151 |
| | $ | 7,522 |
| | $ | 12,327 |
|
________________________ | | (1) | Restated 2015 and 2014 for reclass of debt fees from depreciation and amortization to net interest expense with adoption of ASU 2015-03. |
| | (2) | Consists of un-allocated corporate SG&A costs and intercompany profits, which do not meet the quantitative criteria for determining reportable segments, and gain or loss on convertible debt derivatives. |
| | (3) | Intangible asset impairment related to the rentals businesses which were included in the Institutional Products Group segment. |
| | (4) | Restated 2015 and 2014 for GCM sale on September 30, 2016 and classified as assets held for sale. |
| | (5) | Restated 2014 for rentals businesses sold in July 2015 and classified as assets held for sale. |
|
| Revenue from External Customers by Products and Services |
Net sales by product, are as follows (in thousands): | | | | | | | | | | | | | | 2016 | | 2015 | | 2014 | North America/HME | | | | | | Lifestyle Products | $ | 173,301 |
| | $ | 222,944 |
| | $ | 239,625 |
| Mobility and Seating | 116,722 |
| | 117,232 |
| | 115,776 |
| Respiratory Therapy | 104,631 |
| | 130,349 |
| | 149,063 |
| Other(1) | 3,048 |
| | 3,671 |
| | 3,403 |
|
| $ | 397,702 |
| | $ | 474,196 |
| | $ | 507,867 |
| Institutional Products Group | | | | | | Continuing Care | $ | 64,413 |
| | $ | 87,137 |
| | $ | 102,796 |
| | | | | | | Europe | | | | | | Lifestyle Products | $ | 274,684 |
| | $ | 275,932 |
| | $ | 322,370 |
| Mobility and Seating | 214,713 |
| | 208,730 |
| | 228,163 |
| Respiratory Therapy | 35,030 |
| | 36,373 |
| | 40,661 |
| Other(1) | 15,586 |
| | 15,428 |
| | 19,361 |
|
| $ | 540,013 |
| | $ | 536,463 |
| | $ | 610,555 |
| Asia/Pacific | | | | | | Mobility and Seating | $ | 25,254 |
| | $ | 25,655 |
| | $ | 28,174 |
| Lifestyle Products | 10,161 |
| | 10,277 |
| | 11,772 |
| Continuing Care | 3,521 |
| | 3,115 |
| | 3,956 |
| Respiratory Therapy | 1,244 |
| | 807 |
| | 1,286 |
| Other(1) | 5,166 |
| | 4,688 |
| | 3,757 |
| | $ | 45,346 |
| | $ | 44,542 |
| | $ | 48,945 |
| | | | | | | Total Consolidated | $ | 1,047,474 |
| | $ | 1,142,338 |
| | $ | 1,270,163 |
|
________________________ | | (1) | Includes various services, including repair services, equipment rentals and external contracting. |
|